Moloney murine leukaemia virus (MoMLV) markedly accelerates thymic lymphoma development in mice carrying a transgene in which the human c-myc gene is linked to the CD2 locus control region. To investigate the mechanism of synergy and identify the genes which collaborate with myc in these clonal tumours, we analysed the sites of MoMLV insertion. Analysis of known viral integration loci revealed only a small number of insertions at bmi-1, pim-1 and ahi-1. Further cloning and hybridization analysis revealed a new common integration locus, designated till, which was occupied in 25 out of 77 lymphomas examined, with evidence of multiple clonal insertions in some cases. Mapping relative to established chromosomal markers in interspecific backcross mice located till to mouse chromosome 17, distal to pim-1 and tic-1. These results suggest that the til-1 locus may harbour a novel myecollaborating gene which acts as a target for activation in T cell lymphomas.
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Proviral insertional mutagenesis is a pivotal event in oncogenesis by murine leukaemia virus (MLV) and the study of viral insertion sites in MLV-induced turnouts has led to the identification of a large number of host cell genes relevant to this process (Kung et al., 1991) .
Moreover, the discovery that transgenic mice carrying a dominant oncogene develop tumours much more rapidly if infected early in life with MLV has provided a powerful approach to the identification and complementation mapping of the host cell genes which drive the multi-step evolution of lymphomas (Berns, 1994) . As an example, Eta-myc mice developed B cell lymphomas very rapidly after infection with Moloney MLV (MoMLV), with frequent insertions at several distinct host cell loci including pim-1, pal-1, bmi-1 and bla- 1 (van Lohuizen et al., 1991) . The importance of these insertions to lymphoma development has been amply confirmed for pim-1 and bmi-1, both of which can act independently as dominant oncogenes and are strongly synergistic with myc in lymphomagenesis van Lohuizen et al., 1989; Haupt et al., 1993) . Moreover, a reciprocal pattern of gene activation was seen in pim-1 transgenic mice which developed low incidence lymphomas that could be accelerated by neonatal infection with * Author for correspondence. Fax +44 141 330 6467. e-mail gpma03 @udcf.gla.ac.uk MoMLV, with concomitant insertions at c-myc, N-myc and paL1 loci (van Lohuizen et al., 1989) .
To test the effects of overexpressing c-myc in the T cell lineage, we developed a transgenic model in which the human c-myc oncogene was linked to a T cell-specific regulatory element, the locus control region from the human CD2 gene. We found that CD2-myc transgenic lines developed thymic lymphomas at low frequency and that neonatal infection with MoMLV dramatically accelerated this process, leading to 100% tumour incidence within 80 days of birth (Stewart et al., 1993) .
The tumours were of a homogeneous T cell phenotype (CD3 +, CD8 +, CD4 +/ ), invariably expressed the transgene and contained clonal integrations of MoMLV. Surprisingly, an initial screen of a panel of MoMLVaccelerated CD2 myc tumours showed no evidence of proviral insertions at any of the loci previously identified in Ela myc lymphomas (Stewart et al., 1993) .
These observations suggested that the acceleration of tumour onset in CD2-myc mice was due to the activation of a novel set of myc-collaborating genes by MoMLV.
To test this hypothesis, we undertook the cloning and characterization of proviral integration sites from a representative tumour (tumour 10i; Fig. 1 a) with a small number of exogenous virus insertions (34) as revealed by analysis with a U3 LTR probe . BamHI; S, SstI; P, PstI; RV, EcoRV; RI, EcoRI; Ko KpnI.
ted by complete digestion with EcoRI, which has no recognition site within the M o M L V provirus, and ligation to 2EMBL4 arms. U3-positive clones were selected and plaque purified. Provirus-host junction sequences were then sub-cloned into plasmid vectors and sequenced. Flanking sequence-specific probes free of repetitive DNA elements were generated and used to screen a panel of similar tumours for evidence of a common insertion locus. Of three U3 hybridizationpositive recombinants isolated, one was unique to the tumour of origin, while the other two contained related flanking sequences. Analysis by restriction mapping and DNA sequencing at the insertion site (not shown) showed that these represented two separate viral insertions 535 bp apart at the same locus. Furthermore, screening of a panel of 77 MoMLV-induced lymphomas in CD2-myc mice showed insertions at the same locus in 25 independent tumours. This insertion locus was provisionally designated till (T cell integration locus). Further examples of virus-induced rearrangements of till are shown in Fig. l(b) . The unoccupied site corresponding to probe til-lA was detected in all cases as a 10 kb EcoRI fragment. In some cases, submolar levels of the rearranged allele were detected (see lane 1 in Fig.  1 b) , consistent with its presence in a subset of tumour cells, and more than one clonal insertion could be discerned in several other tumours (Fig. 1 b, lane 3) . Since the virus-accelerated tumours were often oligoclonal, the frequency with which multiple clones carrying insertions at til-1 were observed in an individual tumour was no greater than would be expected from its high rate of occupancy. In the rare examples where proviral insertion ablates gene function in tumours, loss of the unrearranged locus is a common occurrence (Ben-David Lu et al., 1994) . In contrast, it appears that each insertion at til-1 affected only a single allele, suggesting that these were selected by virtue of a gain rather than loss of function. Mapping of integrated proviral elements at the til-1 locus showed that with one possible exception all of these were clustered within the 10 kb EcoRI fragment of mouse DNA. Typically, the EcoRI fragment was increased to around 18 kb as a result ofproviral insertion (Fig. 1 b) . A minority of rearranged EcoRI fragments was of smaller size which could have resulted from the insertion of a defective provirus or a variant which had acquired a novel EcoRI site (Fig. 1 b, lane 4 ). An EcoRI site in env is a hallmark of recombinant mink cell focusforming (MCF) viruses (van der Putten et al., 1981) . However, the rarity of U3-hybridizing EcoRI fragments under 9 kb (Fig. 1 a) suggested that most insertions were due to ecotropic MLV and that the integration of MCF viruses in turnouts was not an obligatory step in the development or acceleration of lymphomas in CD2 myc mice. Proviral orientation was established by digestion with PstI, XhoI/EcoRI and KpnI/EcoRI; the corresponding map of the til-1 locus is shown in Fig. 1 (c) . As can be seen, all proviruses at til-1 were found to be inserted in the same orientation. The two distinct insertions cloned from tumour 10i are indicated by open arrowheads.
The next priority was to discover whether til-1 corresponds to a known proviral insertion locus. Towards this goal, we established the chromosomal location of til-1 using the European Interspecific Backcross (Breen et al., 1994 ). An SstI polymorphism was established by probing parental DNAs (C57BL/6 and Mus spretus) with the til-lA probe and used to follow the segregation of the locus in 64 random backcross progeny. This analysis located til-1 on chromosome 17 close to the D17Mit9 anchor marker. Chromosome 17 harbours two known MoMLV insertion loci [pim-1 and tic-l, formerly designated pim-2; (Hilkens et al., 1986; Breuer et al., 1989) ] and for this reason we analysed the segregation of all three markers in a panel of mice recombinant for chromosome 17. This analysis placed til-1 distal to both loci, with the marker order pim-l- D17Mit61, 28, 176, 137, . In the chromosome 17 panel, 35 % (21/60) had recombinations between pim-1 and tic-l, and 31% (13/42) between tic-1 and till. By extrapolation of the observed recombination frequency to the entire backcross, the genetic distance between tic-1 and til-1 was estimated to be 6 cM (see Fig. 2 ). These results demonstrate that tit-1 is not equivalent to pim-1 or tic-1 but rather represents a novel insertion locus for MoMLV in T cell lymphomas.
Although no known insertion loci were found to be occupied in our previous studies of CD2-myc lympho- (Breen et al., 1994) . Genetic distances (cM) are also indicated. mas (Stewart et aI., 1993) , further screening of the extended panel of 77 lymphomas revealed two tumours with insertions at ahi-1 (Poirier et al., 1988) , and one at each of bmi-1 and pim-1 (Cuypers et al., 1984) (Table 1 ). The pim-1 insertion and one of the ahi-1 insertions occurred in tumours with proviruses at til-1. However, in both of these cases the til-1 rearrangements were submolar and we cannot conclude that these insertions co-existed in the same malignant clone. These results suggest that til-1 may harbour a novel myc-collaborafing gene of relevance for T cell lymphoma development. Furthermore, the large fraction of CD2-myc tumours with no insertions at any known locus (64 %) suggests that further uncharacterized genes may be affected in CD2-myc mouse lymphomas. The marked difference between CD2-myc and Eg myc transgenic mice in the pattern of MoMLV gene activations cannot be explained by a simple B cell/T cell difference, since pim-1 and bmi-1 can be activated in tumours of either lineage (Levy et al., 1993; Tsatsanis et al., 1994) . While c-myc plays a central role in regulating proliferation in many cell types, its over-expression may induce cell death instead of proliferation under unfavourable conditions (Evan et al., 1992) . These observations provide a rationale for the requirement for further genetic events in myc-mediated transformation and oncogenesis. The range of potential myc-collaborating genes is broad, including ras, raf, bcl-2 and p53 in addition to the viral insertion loci already discussed (Berns, 1994; Blyth et al., 1995) . At present we favour the hypothesis that the CD2-myc transgene requires a specific set of myc-collaborating genes due to its unique properties of developmental activation and tissue-specific expression. Our future studies will concentrate on the search for a transcription unit affected by the insertions at til-1.
